III Capital Management »

Halozyme Therapeutics shares owned by III Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by III Capital Management from 13F filings

Historical chart of III Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by III Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by III Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $10M 11M 0.89
2023-03-31 $1.7M 2.0M 0.85

More positions owned by III Capital Management

Royal Caribbean Group Note 6.000% 8/1 (Principal)
Ishares Tr Iboxx Inv Cp Etf Put Option (LQD)
Booking Holdings Note 0.750% 5/0 (Principal)
Ati Note 3.500% 6/1 (Principal)
Insight Enterprises Note 0.750% 2/1 (Principal)
Chart Inds Note 1.000%11/1 (Principal)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Middleby Corp Note 1.000% 9/0 (Principal)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Akamai Technologies Note 0.375% 9/0 (Principal)
Block Note 0.125% 3/0 (Principal)
American Airls Put Option (AAL)
Mongodb Note 0.250% 1/1 (Principal)
Etsy Note 0.125%10/0 (Principal)
Southern Note 3.875%12/1 (Principal)

View all positions for III Capital Management

Top funds holding Halozyme Therapeutics

Wellesley Investment Advisors
Davidson Kempner Capital Management
Lazard Asset Management
Citigroup
Aviva
Wells Fargo & Company
Ameriprise Financial
Tenor Capital Management
Susquehanna International
Victory Capital Management
Citadel Advisors
III Capital Management
Jpmorgan Chase & Co
Wolverine Asset Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Halozyme Therapeutics